Transmission of leprosy: A study of skin and nasal secretions of household contacts of leprosy patients using PCR

被引:88
作者
Job, Charles K.
Jayakumar, Joseph
Kearney, Michael
Gillis, Thomas P.
机构
[1] Natl Hansens Dis Programs, LSU Sch Vet Med, Lab Res Branch, Baton Rouge, LA 70893 USA
[2] Louisiana State Univ, Sch Vet Med, Dept Pathobiol, Baton Rouge, LA 70803 USA
[3] St Thomas Hosp, Chettupattu, India
[4] Leprosy Ctr, Chettupattu, India
关键词
D O I
10.4269/ajtmh.2008.78.518
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
It is generally held that dissemination of Mycobacterium leprae is from nasal mucosa and not through the skin of infected patients. In this study, we evaluated M. leprae in the unbroken skin and nasal secretions of multibacillary (MB) leprosy patients and their contacts. Specimens were examined by direct microscopy and polymerase chain reaction (PCR) for M. leprae DNA. Results showed that 60% of untreated MB leprosy patients examined histologically had acid-fast bacilli in the keratin layer. By PCR studies it was found that 80% of the patients had M. leprae DNA in skin washings and 60% had M. leprae DNA on swabs obtained from the nasal mucosa. Ninety-three contacts of the untreated MB cases were also tested for exposure to M. leprae by analyzing skin washings and nasal secretions by PCR. PCR analysis showed significant skin (17% positive) and nasal muscosal (4%) exposure in contacts before instituting treatment of the index cases. After 2 months of treating the index cases, all contacts tested were negative for M. leprae DNA. These data suggested that both skin and nasal epithelia of untreated MB leprosy patients contribute to the shedding of M. leprae into the environment and contacts of untreated MB cases are at risk for contact with M. leprae through both the nasal mucosa and exposed surfaces of their skin.
引用
收藏
页码:518 / 521
页数:4
相关论文
共 26 条
[1]
Abraham S, 1998, INT J LEPROSY, V66, P131
[2]
[Anonymous], 2006, Wkly Epidemiol Rec, V81, P309
[3]
Chan PC, 1997, PHILIPPINE J MICROBI, V26, P159
[4]
Chatterjee B R, 1976, Lepr India, V48, P643
[5]
NEONATALLY THYMECTOMIZED LEWIS RATS INFECTED WITH MYCOBACTERIUM-LEPRAE - RESPONSE TO PRIMARY INFECTION, SECONDARY CHALLENGE, AND LARGE INOCULA [J].
FIELDSTEEL, AH ;
LEVY, L .
INFECTION AND IMMUNITY, 1976, 14 (03) :736-741
[6]
Leprosy: what is being "eliminated"? [J].
Fine, Paul E. M. .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (01) :2-2
[7]
CLINICAL-TRIAL OF FUSIDIC ACID FOR LEPROMATOUS LEPROSY [J].
FRANZBLAU, SG ;
CHAN, GP ;
GARCIAIGNACIO, BG ;
CHAVEZ, VE ;
LIVELO, JB ;
JIMENEZ, CL ;
PARRILLA, MLR ;
CALVO, RF ;
WILLIAMS, DL ;
GILLIS, TP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1651-1654
[8]
GELBER RH, 1986, INT J LEPROSY, V54, P273
[9]
DISTRIBUTION AND PERSISTENCE OF MYCOBACTERIUM-LEPRAE NASAL CARRIAGE AMONG A POPULATION IN WHICH LEPROSY IS ENDEMIC IN INDONESIA [J].
HATTA, M ;
VANBEERS, SM ;
MADJID, B ;
DJUMADI, A ;
DEWIT, MYL ;
KLATSER, PR .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (04) :381-385
[10]
Hosokawa Atsushi, 1999, Journal of Dermatology (Tokyo), V26, P479